ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
MacroGenics
The Sr. Scientist I/II - Pathology Assay Development leads the development, optimization, and qualification of tissue-based biomarker assays for antibody-drug conjugate and immunotherapy programs. This role generates robust, reproducible data to inform target selection, patient selection, and translational strategies from discovery through early clinical development. The position involves collaborating with cross-functional partners and external vendors to ensure consistent assay performance and data quality.
MacroGenics is a clinical-stage biopharmaceutical company developing next-generation antibody-based therapies to improve the lives of cancer patients. The company is advancing a broad pipeline of novel product candidates spanning oncology, hematology, and autoimmune applications, including antibody-drug conjugates (ADCs), bispecific checkpoint antibodies, and T-cell engagers. MacroGenics has a proven track record of developing FDA-approved therapies in collaboration with global biopharmaceutical partners.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MacroGenics.
Right around the average for this role